Pathogenetic implication of interleukin-2 expressed in preeclamptic decidual tissues: A possible mechanism of deranged vasculature of the placenta associated with preeclampsia

American Journal of Reproductive Immunology

Volumn 38, Issue 2, 1997, Pages 83-88

  Hamai, Yoko ^a   Fujii, Tomoyuki ^a   Yamashita, Takahiro ^a   Kozuma, Shiro ^a   Okai, Takashi ^a   Taketani, Yuji ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Angiogenesis; Endothelial cell; Interleukin 2; Lymphokine activated killer cell; Placenta; Preeclampsia

Indexed keywords

INTERLEUKIN 2; LYMPHOKINE;

ANGIOGENESIS; ARTICLE; DECIDUA; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; HUMAN CELL; LYMPHOCYTE; MONONUCLEAR CELL; PATHOGENICITY; PLACENTA; PREECLAMPSIA; PRIORITY JOURNAL; TROPHOBLAST; VASCULAR ENDOTHELIUM; VASCULARIZATION;

EID: 0030742987     PISSN: 87558920     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0897.1997.tb00280.x     Document Type: Article

References (16)

1. Jenkins DM, Need JA, Scott JS, Morris H, Pepper M: Human leukocyte reaction in severe pre-eclampsia. Br Med J 1978; 1:542-544.
2. Toder V, Blank M, Gleicher N, Voljovich I, Mashiah S, Nebel L: Activity of natural killer cells in normal pregnancy and edema-protein-hypertension gestosis. Am J Obstet Gynecol 1983; 145:7-10.
3. Sunder-Plassmann G, Derfler K, Wagner L, Stockenhuber F, Endler M, Nowotny C, Balcke P: Increased serum activity of interleukin-2 in patients with pre-eclampsia. J Autoimm 1989; 2:203-205.
4. Hara N, Fujii T, Okai T, Taketani Y: Histochemical demonstration of interleukin-2 in decidua cells of patients with preeclampsia. Am J Reprod Immunol 1995; 34:44-51.
5. Carney EW, Lye SJ, Paek W, Zander D, Ritchie JWK: Cellular localization of basic fibroblast growth factor within human placenta throughout gestation. 39th Annual Meeting of the Society for Gynecological Investigation 1992; Abstract: 533.
6. Ferriani RA, Ahmed A, Sharkey A, Smith SK: Colocalization of acidic and basic fibroblast growth factor (FGF) in human placenta and the cellular effects of bFGF in trophoblast cell line JEG-3. Growth Factors 1994; 10:259-268.
7. Shams M, Ahmed A: Localization of mRNA for basic fibroblast growth factor in human placenta. Growth Factors 1994; 11:105-111.
8. Jackson MR, Carney EW, Lye SJ, Knox-Ritchie JW: Localization of two angiogenetic growth factors (PDECGF and VEGF) in human placentae throughout gestation. Placenta 1994; 15:341-353.
9. Jakeman LB, Armanini M, Phillips HS, Ferrara N: Developmental expression of binding sites and messenger ribonucleic acid for vascular endothelial growth factor suggests a role for this protein in vasculogenesis and angiogenesis. Endocrinology 1993; 133:848-859.
10. Ahmed A, Li XF, Dunk C, Whittle MJ, Rushton DI, Rollason T: Colocalisation of vascular endothelial growth factor and its flt-1 receptor in human placenta. Growth Factors 1995; 12:235-243.
11. Mosmann T: Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods 1983; 65:55-63.
12. Sasagawa M, Watanabe S, Ohmomo Y, Honmma S, Kanazawa K, Takeuchi S: Reactivity of two monoclonal antibodies (Troma 1 and CAM 5.2) on Human tissue sections: Analysis of their usefulness as a histological marker in normal pregnancy and trophoblastic disease. Int J Gynecol Obstet 1986; 5:345-356.
13. Wegmann TG, Athanassakis I, Guilbert L, Branch D, Dy M, Menu E, Chaouat G: The role of M-CSF and GM-CSF in fostering placental growth, fetal growth, and fetal survival. Transplantation Proc 1989; 21:566-568.
14. Robb RJ: Interleukin-2: the molecule and its function. Immunol Today 1984; 5:203-209.
15. Starkey PM: Expression on cells of early human pregnancy decidua, of the p75, IL-2 and p145, IL-4 receptor proteins. Immunology 1991; 73:64-70.
16. Ferry BL, Starkey PM, Sargent IL, Watt GMO, Jackson M, Redman CWG. Cell populations in the human early pregnancy decidua: Natural killer activity and response to interleukin-2 of CD56-positive large granular lymphocytes. Immunology 1990; 70:446-452.